Skip to content
Open access · OA via Europe PMC

Remnant-cholesterol-inflammatory-index as a novel predictor of cardiometabolic risk and cardiovascular mortality in elderly patients with severe aortic stenosis.

Mazzone A, Gaggini M, Foffa I, Del Turco S, Minichilli F, Berti S, Vassalle C.

Frontiers in endocrinology · 2026

Abstract

<h4>Background</h4>Inflammaging(definition) activates a vicious cycle common to the progression of structural cardiovascular alterations, cardiometabolic diseases as well as degenerative aortic stenosis (AoS). The remnant cholesterol inflammatory index (RCII) is a new recently proposed biomarker that combines remnant cholesterol and high-sensitivity C-reactive protein, resembling inflammaging. However, the role of RCII in terms of cardiometabolic risk and cardiovascular mortality in AoS elderly patients has not been evaluated still now.<h4>Aim</h4>to assess the association between RCII and cardiovascular risk factors and mortality in AoS elderly patients.<h4>Results</h4>RCII levels correlated with systemic inflammation biomarkers (closer correlation with interleukin-6), glucose, creatinine, vascular endothelial growth factor and frailty in AoS patients. Inverse correlations were observed with albumin (typically reduced in inflammatory states) and with HDL concentration. The Kaplan-Meier survival estimates showed significantly worse survival in patients with elevated RCII levels (p<0.01) (mean follow-up 19 ± 4 months). In an exploratory multivariable Cox analysis, higher RCII was associated with cardiovascular mortality (HR = 3.5, 95% CI: 1.0-12.0).<h4>Conclusion</h4>RCII is associated with cardiometabolic risk and adverse prognosis in elderly patients with AoS, providing an additional perspective on the prognostic implications of the coexistence of lipid abnormalities and low-grade inflammation in this population. However, the limited number of cardiovascular deaths warrants cautious interpretation of this estimate. Moreover, external validation, standardized thresholds, serial measurements, and comparison with established risk models are needed before RCII clinical implementation.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
Europe PMC
DOI
10.3389/fendo.2026.1894558
Canonical
link ↗
Fetched
2026-11-04 MST

Cite this

APA
A, M., M, G., I, F., S, D.T., F, M., S, B., &amp; C., V. (2026). Remnant-cholesterol-inflammatory-index as a novel predictor of cardiometabolic risk and cardiovascular mortality in elderly patients with severe aortic stenosis. <em>Frontiers in endocrinology</em>. https://doi.org/10.3389/fendo.2026.1894558
Vancouver
A M, M G, I F, S DT, F M, S B, et al. Remnant-cholesterol-inflammatory-index as a novel predictor of cardiometabolic risk and cardiovascular mortality in elderly patients with severe aortic stenosis. Frontiers in endocrinology. 2026. doi:10.3389/fendo.2026.1894558.
BibTeX
@article{mazzone2026Remnan, title = {Remnant-cholesterol-inflammatory-index as a novel predictor of cardiometabolic risk and cardiovascular mortality in elderly patients with severe aortic stenosis.}, author = {Mazzone A and Gaggini M and Foffa I and Del Turco S and Minichilli F and Berti S and Vassalle C.}, journal = {Frontiers in endocrinology}, year = {2026}, doi = {10.3389/fendo.2026.1894558}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings